Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Short-Term Investments
Abbott Laboratories
Short-Term Investments Peer Comparison
Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors
Company | Short-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Short-Term Investments
$383m
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-22%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Short-Term Investments
$2m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-45%
|
|
Boston Scientific Corp
NYSE:BSX
|
Short-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Short-Term Investments
$500.5m
|
CAGR 3-Years
32%
|
CAGR 5-Years
16%
|
CAGR 10-Years
0%
|
|
Stryker Corp
NYSE:SYK
|
Short-Term Investments
$82m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-29%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Short-Term Investments
$2.6B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
15%
|
See Also
What is Abbott Laboratories's Short-Term Investments?
Short-Term Investments
383m
USD
Based on the financial report for Dec 31, 2023, Abbott Laboratories's Short-Term Investments amounts to 383m USD.
What is Abbott Laboratories's Short-Term Investments growth rate?
Short-Term Investments CAGR 10Y
-22%
Over the last year, the Short-Term Investments growth was 33%. The average annual Short-Term Investments growth rates for Abbott Laboratories have been 7% over the past three years , 10% over the past five years , and -22% over the past ten years .